National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI

Understanding Cancer Series: Molecular Diagnostics
< Back to Main
In English En español
    Posted: 01/28/2005    Reviewed: 09/01/2006
Page Options
Print This Page  Print This Page
Print This Document  Print This Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
View/Print PDF  View/Print PDF
View/Print PowerPoint  View/Print PowerPoint
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Slide 42 : Clinical Trials: Making the Future the Present previous

Molecular diagnostics and its newly developed techniques for examining the molecular signatures of cancer cells--protein as well as gene patterns--offer great promise for revolutionizing our approaches to screening, diagnosis, and classification for many different kinds of cancer. Participation in the clinical trials that will validate these new approaches will lead to significant improvements in care for cancer patients in the not-too-distant future.

Clinical Trials: Making the Future the Present

< Previous  |  Index


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov